Press Releases and Statements

The U.S. dietary supplement industry commends FDA for taking action to protect consumers by calling out marketers who make illegal and unsubstantiated drug claims related to COVID-19.

OTC manufacturers share FDA’s commitment to providing consumers with products that are safe and effective.

Consumer Healthcare Products Association (CHPA) President and CEO, Scott Melville, issued the following statement upon final passage of the CARES Act.

In this newly created role, Dr. Troup will lead strategy development and direct CHPA’s work on dietary supplements issues, evaluating science, shaping policy, and collaborating with stakeholders for this important, growing consumer health category.

The types of evidence used to monitor dietary supplement safety, including adverse event reports, emergency room visits and poison control center data.

The four leading trade associations representing the dietary supplement industry are concerned that some marketers of dietary supplements may be promoting them with claims of prevention or treatment of Coronavirus.

Medical and patient groups, public health experts, FDA, and others join the Consumer Healthcare Products Association in opposing the addition of acetaminophen to the Proposition 65 list.

PCPC, the CHPA, and their member companies are aligned with FDA, CDC, the U.S. Surgeon General, AAD, the Skin Cancer Foundation and health professionals worldwide about the important health benefits sunscreens provide as part of a safe sun regimen to help prevent sunburn and reduce skin cancer risk.

CHPA, the PCPC, and their member companies are aligned with FDA, CDC, the U.S. Surgeon General, and other health professionals worldwide about the important health benefits sunscreens provide as part of a safe sun regimen.

The observational Internet survey results pre-published in the American Journal of Gastroenterology reporting an association between use of proton-pump inhibitor (PPI) medicines and self-reported positive tests for COVID-19 among people taking PPIs do not prove cause-and-effect.

The 2019 results from the NIDA and University of Michigan’s annual drug abuse survey, Monitoring the Future, show that the number of teens using OTC cough medicine containing DXM to get high decreased slightly.

CHPA congratulates Dr. Hahn on his confirmation today as the 24th Commissioner of the U.S. Food and Drug Administration. Commissioner Hahn’s experience as a practicing oncologist, researcher, and former chief medical officer of the MD Anderson Cancer Center make him well-suited to his new role.